3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:——
公开号:US20040198720A1
公开(公告)日:2004-10-07
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调制和/或抑制异常细胞增殖。
3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
申请人:——
公开号:US20030225152A1
公开(公告)日:2003-12-04
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调制和/或抑制异常细胞增殖。
3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Andrews W. Steven
公开号:US20060025413A1
公开(公告)日:2006-02-02
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调节和/或抑制异常细胞增殖。
3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Allergan, Inc.
公开号:US06765012B2
公开(公告)日:2004-07-20
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.